Register Now: Image-Based Risk: The Next Frontier in Breast Cancer Screening
|Articles|January 1, 2009

Diagnostic Imaging

  • Diagnostic Imaging Vol 31 No 1
  • Volume 31
  • Issue 1

Economic woes affect attendance

Author(s)James Brice

A big drop in exhibitor attendance led to an overall 5% decline in the number ofpeople who attended the 2008 RSNA meeting. Audited totals released by the RSNAafter the end of sessions on Dec. 5 indicate that 58,795 people attended the weeklongscientific assembly and meeting.

A big drop in exhibitor attendance led to an overall 5% decline in the number of people who attended the 2008 RSNA meeting. Audited totals released by the RSNA after the end of sessions on Dec. 5 indicate that 58,795 people attended the weeklong scientific assembly and meeting.

Vendor attendance declined 12% to 24,683. According to the RSNA, 726 technical exhibits occupied 516,100 square feet, down 4% from the 2007 total.

Many exhibitors expressed concerned during the week about the growing international economic crisis prompted by a historic collapse of global financial markets in October. The U.S. Bureau of Labor Statistics announced during the conference week that U.S. employers had cut 533,000 jobs in November, the biggest one-month cut since December 1974. Medical imaging equipment sales declines have dogged the industry at least since the initiation of Medicare rate cuts for high-tech outpatient imaging procedures in January 2007.

Despite a modest increase in preregistration numbers, professional attendance fell 1% to 27,586. Many attendees mentioned that they did not notice a change in the overall traffic across the Lake Shore Drive bridge from the North and South buildings to the Lakeside Center. Attendance by guests rose 7% to 6526.

Articles in this issue

Related to this article

Emerging Research Insights and New Advances in Neuroradiology
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Current Perspectives on Integrating AI into Radiology
In a recent interview with Diagnostic Imaging, Joseph Cavallo, MD, MBA, offered insights on post-deployment monitoring with AI, the potential for improved workflow efficiency and the ongoing challenge of balancing essential clinical skills and AI literacy in the training of radiology residents and fellows.